1. BRENTUXIMAB VEDOTIN PLUS VIGEPP CHEMOTHERAPY FOR RELAPSED/REFRACTORY ADOLESCENT HODGKIN LYMPHOMA. (October 2022) Authors: Tsaplina, N.; Valiev, T. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Epigenetic therapy in childhood acute myeloid leukemias. (October 2019) Authors: Popa, A.; Nemirovchenko, V.; Tiganova, O.; Subbotina, N.; Serebryakova, I.; Palladina, A.; Tupitsin, N.; Kurdjukov, B.; Valiev, T.; Mentkwvich, G. Journal: Leukemia research Issue: Volume 85(2019)Supplement 1 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rituximab reduction for pediatric advanced-stage Burkitt lymphoma. (October 2019) Authors: Valiev, T.; Popa, A.; Mentkevich, G. Journal: Leukemia research Issue: Volume 85(2019)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗